Casodex 50Mg With 28 Tablets (Bicalutamide)

Category

Oncology medication

Line

Antineoplastics

Brand

Casodex

Molecule

Bicalutamide

Presentation

28 tablets of 50 mg

Laboratory

Astrazeneca

Indications

Casodex (bicalutamide) is indicated for the treatment of metastatic prostate cancer, as well as for the management of localized prostate cancer in combination with androgen deprivation therapy. This medication acts as an androgen receptor antagonist, inhibiting the action of testosterone in prostate cells, which can help stop or slow tumor growth. Its use is recommended in patients who have been diagnosed and treated by a specialized oncology physician. It may also be indicated in cases of feminization syndrome in men, although its use must be evaluated by a healthcare professional.

Composition

Each Casodex tablet contains 50 mg of bicalutamide as the active ingredient, as well as excipients that allow for the tablet's formulation.

Contraindications

Casodex is contraindicated in patients with known hypersensitivity to bicalutamide or any of the excipients in the formulation. It should not be administered to women or children. It is contraindicated in patients with severe liver diseases, as the drug's metabolism may be affected. Furthermore, its use in combination with other medications that may interfere with its efficacy should be avoided.

Precautions

Caution should be exercised when using Casodex in patients with a history of liver disease, as regular monitoring of liver functions is required. It is important to evaluate renal function before initiating treatment and to monitor it during treatment. Patients should be informed about the possibility of side effects, such as changes in sexual function, and the need to consult their doctor for any unusual symptoms.

Storage

Store in a cool, dry place, at a temperature not exceeding 30°C. Keep out of reach of children. Do not use after the expiration date indicated on the package.

Prescription required.

Consult your doctor.